Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.
about
The association of health literacy with adherence in older adults, and its role in interventions: a systematic meta-reviewMedication adherence in gout: a systematic reviewImpaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of goutA Prospective Follow-Up of Adipocytokines in Cohort Patients With Gout: Association With Metabolic Syndrome But Not With Clinical Inflammatory Findings: Strobe-Compliant Article.A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan Database.Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents.Utility of the Morisky Medication Adherence Scale in gout: a prospective study.A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.Factors influencing medication adherence in patients with gout: A descriptive correlational study.Comorbidity of gout and rheumatoid arthritis in a large population database.Severe tophaceous gout and disability: changes in the past 15 years.Gout Self-Management in African-American Veterans: A Qualitative Exploration of Challenges and Solutions from Patients' Perspectives.Adherence with urate-lowering therapies among male patients with gout in a routine clinical setting.The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort.Allopurinol adherence among patients with gout: an Italian general practice database study.Characterization of adherence and persistence profile in a real-life population of patients treated with adalimumab.Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study.The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis.Individualising the dose of allopurinol in patients with gout.Education and non-pharmacological approaches for gout.Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review.Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis.Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study.Improving adherence to gout therapy: an expert review.
P2860
Q26786093-2AE34FB5-3143-426C-8B6D-904D7872808FQ27694691-44F4C600-0048-48DC-96D2-B4F9585434DCQ34476295-5AD5F344-BDF8-4DB0-BE15-7F9BFF877360Q35857780-930EE58D-BBF6-49E9-BCB5-6A1093994AE9Q36302521-5D00CEB7-7086-4BFF-A460-120E1EB0F3D2Q37068967-62261A6A-E8F2-4D1A-8114-2EBB165824F9Q37485303-906DBE8C-B892-4967-B5B1-908FF37BFE5BQ38662236-BB65C27F-587D-4512-91A5-01170F006ED3Q38670679-E72B6707-8656-495E-9ABF-C1924C34F691Q39193476-41F78F91-E347-4121-86AB-894916F2F493Q39386597-B2729B8F-654F-4D3D-9B9B-03BAED5B36DCQ40366290-190DEB41-8D4D-496E-A04B-7BC8B2CCB4D2Q40770483-29A13C88-ED8A-4099-AA4F-AA8BFABFB0D8Q41111925-AA52574B-F48C-4E2F-B0D2-AB7737558F36Q41433599-5B59FF2D-9D18-4F5D-9561-DA4393DF5F07Q47258336-DAEF0959-30A2-4FAC-B046-6CAD9ED30573Q47658083-9AA790C6-C46A-4D51-AFF1-38002C15DD24Q47943997-AE9FC850-3A0A-4CD8-A651-3B7C8020E3F6Q48266996-58D6367F-EFFD-48C6-B990-B6450B48B51BQ49616112-1F87BA26-0135-4ADE-B9DB-8C38B23AD0AFQ50075562-0A501E5D-148A-4B7F-9A62-25C47A764AABQ52593279-79CE89AC-F392-403B-B129-2CE7216A0699Q53676007-C34C92E2-A9FD-4672-A5D7-385A816E6F5BQ55220842-3D681C8A-ADA2-45C2-BA33-AB2E0AB92337
P2860
Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Rates of adherence and persist ...... among gout patients in Israel.
@en
Rates of adherence and persist ...... among gout patients in Israel.
@nl
type
label
Rates of adherence and persist ...... among gout patients in Israel.
@en
Rates of adherence and persist ...... among gout patients in Israel.
@nl
prefLabel
Rates of adherence and persist ...... among gout patients in Israel.
@en
Rates of adherence and persist ...... among gout patients in Israel.
@nl
P2093
P2860
P50
P356
P1433
P1476
Rates of adherence and persist ...... among gout patients in Israel.
@en
P2093
Nadya Shamrayevsky
Raanan Raz
Varda Shalev
P2860
P304
P356
10.1093/RHEUMATOLOGY/KES431
P577
2013-02-07T00:00:00Z